Clinical Trial Update: TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating TL938 in combination with Trastuzumab for HER2-positive metastatic colorectal cancer; the study is currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• TL938
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Suzhou Teligene Ltd. | Conditions: Colorectal Cancer Metastatic, Advanced Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING